Cancer Center Research Trials
Our patients are offered the opportunity to participate
in national studies approved by the National Cancer Institute (NCI). We are
very active in clinical research in finding new treatments for
patients. We have a dedicated team coordinating the data from our
clinical trials.
Through the NCI we also have the ability to offer our patients very select
trials through other research groups such as the NSABP
(National Surgical Adjuvant Breast Project),
ECOG
(Eastern Cooperative Oncology Group) and COG
(Children's Oncology Group).

The RTOG is a national study group that offers the latest studies in
radiation therapy combined with chemotherapy or other treatments. We
currently have active studies in prostate, head & neck, breast, and pancreatic
cancers. We are constantly offering new protocols to our patients. The following
protocols are currently active:
RTOG 98-04
RTOG P0011
RTOG H-0022
RTOG P0126
RTOG 0211
RTOG 0212
RTOG 0213
RTOG 0214
RTOG 0239
MammoSite
RTS
GliaSite RTS

In House Clinical Trials
We are constantly offering
patients clinical trials developed in our cancer centers. Some of these
studies include combinations or slight alterations in standard treatments.
All our studies must be approved by our Institutional Review Board
that set clinical and ethical standards for our cancer centers. Many
of the current standards of practice for cancers of the cervix, anal canal and
esophagus were conceived and piloted in in-house clinical studies by members of
AROS with the help of local oncologists.
